Von dem Buch Risk-based Management of GMP Audits: An Approach for a Medium-sized Pharmaceutical Company (English Edition) haben wir 2 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: Hieble-Gerhard, Viola: Risk-based Management of GMP Audits: An Approach for a Medium-sized Pharmaceutical Company (English Edition) (ISBN: 9783828853218) 2011, Erstausgabe, in Englisch, auch als eBook.Nur diese Ausgabe anzeigen…
85%: Viola Hieble-Gerhard: Risk-based Management of GMP Audits - An Approach for a Medium-sized Pharmaceutical Company (ISBN: 9783828824447) 2010, Tectum Verlag, in Deutsch, Taschenbuch.Nur diese Ausgabe anzeigen…
Risk-based Management of GMP Audits: An Approach for a Medium-sized Pharmaceutical Company (English Edition)
10 Angebote vergleichen
| Preise | 2013 | 2014 | 2017 | 2018 |
|---|---|---|---|---|
| Schnitt | € 19,99 | € 19,99 | € 19,99 | € 13,33 |
| Nachfrage |
1
Risk-based Management of GMP Audits
DE NWISBN: 9783828853218 bzw. 3828853218, in Deutsch, Tectum Wissenschaftsverlag, neu.
Lieferung aus: Deutschland, sofort lieferbar.
Within the European Union the manufacturing of medicinal products has undoubtedly reached a very high quality level. The principles of Good Manufacturing Practice (GMP) are required by law. A relevant part of the quality of finished products depends on the quality of the starting material, especially of the active pharmaceutical ingredients (APIs). In the framework of globalisation and due to the ever-increasing cost pressure APIs are meanwhile sourced in a worldwide market, mainly in Asia. The risk of sourcing substandard, contaminated or adulterated products is an existent fact. Therefore, the quality management systems of the pharmaceutical manufacturers need to be adjusted to this challenge. Many initiatives have been started by authorities and the pharmaceutical industry during the last years in order to avoid the use of Counterfeit APIs or Rogue APIs and unclear supply chains. Indeed, full assessment of GMP compliance of API suppliers represents a cost-intensive and resource-requiring process. Setting.
Within the European Union the manufacturing of medicinal products has undoubtedly reached a very high quality level. The principles of Good Manufacturing Practice (GMP) are required by law. A relevant part of the quality of finished products depends on the quality of the starting material, especially of the active pharmaceutical ingredients (APIs). In the framework of globalisation and due to the ever-increasing cost pressure APIs are meanwhile sourced in a worldwide market, mainly in Asia. The risk of sourcing substandard, contaminated or adulterated products is an existent fact. Therefore, the quality management systems of the pharmaceutical manufacturers need to be adjusted to this challenge. Many initiatives have been started by authorities and the pharmaceutical industry during the last years in order to avoid the use of Counterfeit APIs or Rogue APIs and unclear supply chains. Indeed, full assessment of GMP compliance of API suppliers represents a cost-intensive and resource-requiring process. Setting.
2
Risk-based Management of GMP Audits - An Approach for a Medium-sized Pharmaceutical Company
DE NWISBN: 9783828853218 bzw. 3828853218, in Deutsch, Tectum, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
Risk-based Management of GMP Audits: Within the European Union the manufacturing of medicinal products has undoubtedly reached a very high quality level. The principles of Good Manufacturing Practice (GMP) are required by law. A relevant part of the quality of finished products depends on the quality of the starting material, especially of the active pharmaceutical ingredients (APIs). In the framework of globalisation and due to the ever-increasing cost pressure APIs are meanwhile sourced in a worldwide market, mainly in Asia. The risk of sourcing substandard, contaminated or adulterated products is an existent fact. Therefore, the quality management systems of the pharmaceutical manufacturers need to be adjusted to this challenge. Many initiatives have been started by authorities and the pharmaceutical industry during the last years in order to avoid the use of Counterfeit APIs or Rogue APIs and unclear supply chains. Indeed, full assessment of GMP compliance of API suppliers represents a cost-intensive and resource-requiring process. Setting reasonable priorities in the audit programme of a pharmaceutical company becomes possible through a risk-based management. Englisch, Ebook.
Risk-based Management of GMP Audits: Within the European Union the manufacturing of medicinal products has undoubtedly reached a very high quality level. The principles of Good Manufacturing Practice (GMP) are required by law. A relevant part of the quality of finished products depends on the quality of the starting material, especially of the active pharmaceutical ingredients (APIs). In the framework of globalisation and due to the ever-increasing cost pressure APIs are meanwhile sourced in a worldwide market, mainly in Asia. The risk of sourcing substandard, contaminated or adulterated products is an existent fact. Therefore, the quality management systems of the pharmaceutical manufacturers need to be adjusted to this challenge. Many initiatives have been started by authorities and the pharmaceutical industry during the last years in order to avoid the use of Counterfeit APIs or Rogue APIs and unclear supply chains. Indeed, full assessment of GMP compliance of API suppliers represents a cost-intensive and resource-requiring process. Setting reasonable priorities in the audit programme of a pharmaceutical company becomes possible through a risk-based management. Englisch, Ebook.
3
Risk-based Management of GMP Audits
DE PB NWISBN: 3828824447 bzw. 9783828824447, in Deutsch, Taschenbuch, neu.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Versandkostenfrei.
Risk-based Management of GMP Audits ab 24.9 € als Taschenbuch: An Approach for a Medium-sized Pharmaceutical Company. 1., Aufl.. Aus dem Bereich: Bücher, Taschenbücher, Wirtschaft & Soziales,.
Risk-based Management of GMP Audits ab 24.9 € als Taschenbuch: An Approach for a Medium-sized Pharmaceutical Company. 1., Aufl.. Aus dem Bereich: Bücher, Taschenbücher, Wirtschaft & Soziales,.
4
Risk-based Management of GMP Audits: An Approach for a Medium-sized Pharmaceutical Company (English Edition) (2011)
EN NW FE EB DLISBN: 9783828853218 bzw. 3828853218, in Englisch, 152 Seiten, Tectum Wissenschaftsverlag, neu, Erstausgabe, E-Book, elektronischer Download.
Lieferung aus: Deutschland, E-Book zum Download, Versandkostenfrei.
Within the European Union the manufacturing of medicinal products has undoubtedly reached a very high quality level. The principles of Good Manufacturing Practice (GMP) are required by law. A relevant part of the quality of finished products depends on the quality of the starting material, especially of the active pharmaceutical ingredients (APIs). In the framework of globalisation and due to the ever-increasing cost pressure APIs are meanwhile sourced in a worldwide market, mainly in Asia. The risk of sourcing substandard, contaminated or adulterated products is an existent fact. Therefore, the quality management systems of the pharmaceutical manufacturers need to be adjusted to this challenge. Many initiatives have been started by authorities and the pharmaceutical industry during the last years in order to avoid the use of Counterfeit APIs or Rogue APIs and unclear supply chains. Indeed, full assessment of GMP compliance of API suppliers represents a cost-intensive and resource-requiring process. Setting reasonable priorities in the audit programme of a pharmaceutical company becomes possible through a risk-based management. Kindle Edition, Ausgabe: 1, Format: Kindle eBook, Label: Tectum Wissenschaftsverlag, Tectum Wissenschaftsverlag, Produktgruppe: eBooks, Publiziert: 2011-11-01, Freigegeben: 2011-11-01, Studio: Tectum Wissenschaftsverlag.
Within the European Union the manufacturing of medicinal products has undoubtedly reached a very high quality level. The principles of Good Manufacturing Practice (GMP) are required by law. A relevant part of the quality of finished products depends on the quality of the starting material, especially of the active pharmaceutical ingredients (APIs). In the framework of globalisation and due to the ever-increasing cost pressure APIs are meanwhile sourced in a worldwide market, mainly in Asia. The risk of sourcing substandard, contaminated or adulterated products is an existent fact. Therefore, the quality management systems of the pharmaceutical manufacturers need to be adjusted to this challenge. Many initiatives have been started by authorities and the pharmaceutical industry during the last years in order to avoid the use of Counterfeit APIs or Rogue APIs and unclear supply chains. Indeed, full assessment of GMP compliance of API suppliers represents a cost-intensive and resource-requiring process. Setting reasonable priorities in the audit programme of a pharmaceutical company becomes possible through a risk-based management. Kindle Edition, Ausgabe: 1, Format: Kindle eBook, Label: Tectum Wissenschaftsverlag, Tectum Wissenschaftsverlag, Produktgruppe: eBooks, Publiziert: 2011-11-01, Freigegeben: 2011-11-01, Studio: Tectum Wissenschaftsverlag.
5
Risk-based Management of GMP Audits als eBook von Viola Hieble-Gerhard
DE NWISBN: 9783828853218 bzw. 3828853218, in Deutsch, Tectum Wissenschaftsverlag, neu.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Versandkostenfrei.
Risk-based Management of GMP Audits ab 19.99 EURO An Approach for a Medium-sized Pharmaceutical Company.
Risk-based Management of GMP Audits ab 19.99 EURO An Approach for a Medium-sized Pharmaceutical Company.
6
Risk-based Management of GMP Audits
DE NWISBN: 9783828853218 bzw. 3828853218, in Deutsch, neu.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Versandkostenfrei.
Risk-based Management of GMP Audits ab 19.99 € als pdf eBook: An Approach for a Medium-sized Pharmaceutical Company. Aus dem Bereich: eBooks, Wirtschaft,.
Risk-based Management of GMP Audits ab 19.99 € als pdf eBook: An Approach for a Medium-sized Pharmaceutical Company. Aus dem Bereich: eBooks, Wirtschaft,.
7
Risk-based Management of GMP Audits als Taschenbuch von Viola Hieble-Gerhard
DE PB NWISBN: 9783828824447 bzw. 3828824447, in Deutsch, Tectum Verlag, Taschenbuch, neu.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Versandkostenfrei.
Risk-based Management of GMP Audits ab 24.9 EURO An Approach for a Medium-sized Pharmaceutical Company. 1., Aufl.
Risk-based Management of GMP Audits ab 24.9 EURO An Approach for a Medium-sized Pharmaceutical Company. 1., Aufl.
8
Risk-based Management of GMP Audits (2010)
DE PB NWISBN: 9783828824447 bzw. 3828824447, in Deutsch, Tectum, Taschenbuch, neu.
Lieferung aus: Deutschland, Sofort lieferbar.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
9
Risk-based Management of GMP Audits (2010)
DE PB NWISBN: 9783828824447 bzw. 3828824447, in Deutsch, Tectum, Taschenbuch, neu.
Lieferung aus: Schweiz, Versandfertig innert 1-2 Werktagen.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
10
Risk-based Management of GMP Audits
DE NWISBN: 9783828824447 bzw. 3828824447, in Deutsch, neu.
Lieferung aus: Deutschland, Lieferzeit: 11 Tage.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…